Ivan Rosas
Section Chief of Pulmonary, Critical Care, and Sleep Medicine · Baylor College of Medicine
Credentials: · · · · ·
History
- Present
Critical Care Section · Baylor College of Medicine
Internal Medicine
Research
Science Advances · 2020 · 1,172 citations
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
New England Journal of Medicine · 2021 · First of 23 authors · 798 citations
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
American Journal of Physiology-Lung Cellular and Molecular Physiology · 2015 · 756 citations
- GH
51 papers
- SE
51 papers
39 papers
38 papers
38 papers
- HG
33 papers
- TD
28 papers
- SP
27 papers · 27 as a resident
Grants
- 2024–2028
BCM-Respiratory Research Training
National Heart, Lung, and Blood Institute · T32
PI · $887.8K · Baylor College of Medicine
- 2016–2026
Clinical Genetics and Screening for Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
PI · $10M · Brigham and Women's Hospital
- 2017–2024
Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · U01
PI · $3.8M · University of Alabama at Birmingham
- 1993–2022
Research Training in Lung Disease
National Heart, Lung, and Blood Institute · T32
Contact PI · $540.6K · Baylor College of Medicine
Clinical trials
- 2017–2021
Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Principal investigator · Completed · Phase 2
Brigham and Women's Hospital
- 2009–2014
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Principal investigator · Completed · Phase 3
Duke University
- 2026–2027
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Site PI · Recruiting · Phase 2
Rein Therapeutics